Kevin W. Burton
Directeur des opérations chez Aeon Bioscience, Inc.
Profil
Kevin W.
Burton is currently the Chief Operating Officer at Aeon Bioscience, Inc. He previously worked as a Research Director at Brookwood Pharmaceuticals, Inc., a Principal at Nektar Therapeutics, DURECT Corp., and Purdue Pharma LP.
Burton holds a doctorate degree from the University of Kentucky College of Pharmacy.
Postes actifs de Kevin W. Burton
| Sociétés | Poste | Début |
|---|---|---|
Aeon Bioscience, Inc.
 Aeon Bioscience, Inc. Medical SpecialtiesHealth Technology Aeon Bioscience, Inc. develops drug-eluting polymers and stents that overcome concerns of late stent thrombosis. It addresses the medical challenges for cardiac patients. The company was founded by Christopher E. Banas and Paul Castella on January 29, 2007 and is headquartered in Birmingham, AL. | Directeur des opérations | - |
Anciens postes connus de Kevin W. Burton
| Sociétés | Poste | Fin |
|---|---|---|
Brookwood Pharmaceuticals, Inc.
 Brookwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Surmodics, Inc., Brookwood Pharmaceuticals, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Birmingham, AL. Arthur J. Tipton has been the CEO of the company since 2005. Brookwood Pharmaceuticals was acquired by Surmodics, Inc. from Southern Research Institute on August 01, 2007 for $55.50 million. | Directeur Technique/Scientifique/R&D | - |
| DURECT CORPORATION | Corporate Officer/Principal | - |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Corporate Officer/Principal | - |
Formation de Kevin W. Burton
| University of Kentucky College of Pharmacy | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| DURECT CORPORATION | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| Entreprise privées | 3 |
|---|---|
Aeon Bioscience, Inc.
Aeon Bioscience, Inc. Medical SpecialtiesHealth Technology Aeon Bioscience, Inc. develops drug-eluting polymers and stents that overcome concerns of late stent thrombosis. It addresses the medical challenges for cardiac patients. The company was founded by Christopher E. Banas and Paul Castella on January 29, 2007 and is headquartered in Birmingham, AL. | Health Technology |
Purdue Pharma LP
Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Health Technology |
Brookwood Pharmaceuticals, Inc.
Brookwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Surmodics, Inc., Brookwood Pharmaceuticals, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Birmingham, AL. Arthur J. Tipton has been the CEO of the company since 2005. Brookwood Pharmaceuticals was acquired by Surmodics, Inc. from Southern Research Institute on August 01, 2007 for $55.50 million. | Health Technology |
